Novartis, Merck & Allergan Join Those Raising U.S. Drug Prices for 2020
One-Quarter of Every U.S. Healthcare Dollar Wasted
U.S. Senators Tell Drug Company Execs Pricing Is Morally Repugnant
The Value of Repeat Antibody Testing in Lupus Patients
U.S. Health Spending Is Twice Other Countries’, with Worse Results
Inside Cambodia’s Struggles with Poverty, Dearth of Trained Rheumatologists
Healthcare Prices Hard to Find Online
Rheumatologists Concerned High Healthcare Costs May Encourage Patients to Forgo, Delay Treatment
Pfizer Hikes U.S. Prices of 91 Drugs by Average 20% in 2017
- 1
- 2
- 3
- …
- 5
- Next Page »